Plant Tissue Culture Market Share, Size, Trends, Industry Analysis Report, By End-Use (Agriculture, Research, Gardening & Decoration, Forestry & Botanical Garden, Others); By Crop Type; By Stage; By Region; Segment Forecast, 2022 - 2030
Description
The global plant tissue culture market size is expected to reach USD 1,367.31 Million by 2034 according to a new study by Polaris Market Research. The report “Plant Tissue Culture Market Share, Size, Trends, Industry Analysis Report, By End-Use (Agriculture, Research, Gardening & Decoration, Forestry & Botanical Garden, Others); By Crop Type; By Stage; By Region; Segment Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Rapid improvements in cell culture techniques and increasing demand for virus-free crops and many others will only further boost the market's development and provide significant potential prospects throughout the forecast period. One of the fascinating advancements in plant science is cell culture technology. Further, cell culture technologies, in conjunction with recombinant DNA technologies, are required to generate transgenic plants. However, techniques such as anther/pollen/ovule culture and cell culture can be used for plant breeding or to supplement conventional breeding. Isolated microspore cultivation has recently emerged as a breeding technique and laboratory for numerous genetic alterations.
Cell culture can be used to produce virus-free plants, which can help to reduce losses incurred by phytopathogens. Embryo culture has many possible applications, from overcoming root formation to facilitating inter-specific hybridization. Plant tissue culture and cell culture are important approaches for genetic storage, either by storing structured tissue at low temperatures or by freeze-drying cell or embryo culture.
Based on the crop type, the floriculture plants segment accounted for the leading share in the market. This is attributable to the rise of the cosmetics and personal care business and increased knowledge of the medicinal qualities of flowers, which is also contributing to market growth. Floral crops also provide decent pricing virtually all year, and the lock-in time from seeding to harvesting is much shorter than for other routine crops. Thus, floriculture is high in demand due to its benefits among various crop types.
Market players such as Rubi Bio LLC, Booms Pharm, Caisson Laboratories, Inc., Australis Capital Inc., Agriforest Bio-Technologies, Labland Biotech Private Limited, Alpha Laboratories, Phytoclone Inc., Merck KGaA, Thomas Scientific (The Carlyle Group), Phytotech Laboratories, Inc., and Tissue-Grown Corporation are some key players operating in the global market.
In March 2021, Australis Capital Inc. (AUSA) announced a joint venture relationship with 3 Rivers Biotech Inc., a premier agricultural techniques business, especially for commercial-scale micropropagation, also known as Plant Tissue Culture (PTC), for cannabis, hemp, and traditional crops.
Polaris Market Research has segmented the plant tissue culture market report based on crop type, stage, plant, end-use, and region:
Plant Tissue Culture, Crop Type Outlook (Revenue - USD Million, 2020 - 2034)
Banana
Floriculture
Gerbera
Carnation
Others
Wood Producing
Fruit
Vegetable
Ornamental
Aquatic
Others
Plant Tissue Culture, Stage Outlook (Revenue - USD Million, 2020 - 2034)
Explant Preparation & Inoculation
Multiplication
Hardening
Plant Tissue Culture, Plant Outlook (Revenue - USD Million, 2020 - 2034)
Annual
Biennial
Perennial
Plant Tissue Culture, End-Use Outlook (Revenue - USD Million, 2020 - 2034)
Agriculture
Research
Gardening & Decoration
Forestry & Botanical Garden
Others
Plant Tissue Culture, Regional Outlook (Revenue - USD Million, 2020 - 2034)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Russia
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rapid improvements in cell culture techniques and increasing demand for virus-free crops and many others will only further boost the market's development and provide significant potential prospects throughout the forecast period. One of the fascinating advancements in plant science is cell culture technology. Further, cell culture technologies, in conjunction with recombinant DNA technologies, are required to generate transgenic plants. However, techniques such as anther/pollen/ovule culture and cell culture can be used for plant breeding or to supplement conventional breeding. Isolated microspore cultivation has recently emerged as a breeding technique and laboratory for numerous genetic alterations.
Cell culture can be used to produce virus-free plants, which can help to reduce losses incurred by phytopathogens. Embryo culture has many possible applications, from overcoming root formation to facilitating inter-specific hybridization. Plant tissue culture and cell culture are important approaches for genetic storage, either by storing structured tissue at low temperatures or by freeze-drying cell or embryo culture.
Based on the crop type, the floriculture plants segment accounted for the leading share in the market. This is attributable to the rise of the cosmetics and personal care business and increased knowledge of the medicinal qualities of flowers, which is also contributing to market growth. Floral crops also provide decent pricing virtually all year, and the lock-in time from seeding to harvesting is much shorter than for other routine crops. Thus, floriculture is high in demand due to its benefits among various crop types.
Market players such as Rubi Bio LLC, Booms Pharm, Caisson Laboratories, Inc., Australis Capital Inc., Agriforest Bio-Technologies, Labland Biotech Private Limited, Alpha Laboratories, Phytoclone Inc., Merck KGaA, Thomas Scientific (The Carlyle Group), Phytotech Laboratories, Inc., and Tissue-Grown Corporation are some key players operating in the global market.
In March 2021, Australis Capital Inc. (AUSA) announced a joint venture relationship with 3 Rivers Biotech Inc., a premier agricultural techniques business, especially for commercial-scale micropropagation, also known as Plant Tissue Culture (PTC), for cannabis, hemp, and traditional crops.
Polaris Market Research has segmented the plant tissue culture market report based on crop type, stage, plant, end-use, and region:
Plant Tissue Culture, Crop Type Outlook (Revenue - USD Million, 2020 - 2034)
Banana
Floriculture
Gerbera
Carnation
Others
Wood Producing
Fruit
Vegetable
Ornamental
Aquatic
Others
Plant Tissue Culture, Stage Outlook (Revenue - USD Million, 2020 - 2034)
Explant Preparation & Inoculation
Multiplication
Hardening
Plant Tissue Culture, Plant Outlook (Revenue - USD Million, 2020 - 2034)
Annual
Biennial
Perennial
Plant Tissue Culture, End-Use Outlook (Revenue - USD Million, 2020 - 2034)
Agriculture
Research
Gardening & Decoration
Forestry & Botanical Garden
Others
Plant Tissue Culture, Regional Outlook (Revenue - USD Million, 2020 - 2034)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Russia
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
117 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Others
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. U.S. Sterilization Container Systems Market Insights
- 4.1. U.S. Sterilization Container Systems Market – Material Snapshot
- 4.2. U.S. Sterilization Container Systems Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Expansion of Ambulatory Surgical Centers (ASCs)
- 4.2.1.2. Adoption of Advanced Filtration/Valve Technologies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High initial cost of sterilization containers
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. U.S. Sterilization Container Systems Market Material Trends
- 4.6. Value Chain Analysis
- 5. U.S. Sterilization Container Systems Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. U.S. Sterilization Container Systems Market, by Product, 2020-2034 (USD Million)
- 5.3. Sterilization Containers
- 5.3.1. U.S. Sterilization Container Systems Market, by Sterilization Containers, 2020–2034 (USD Million)
- 5.4. Accessories
- 5.4.1. U.S. Sterilization Container Systems Market, by Accessories, 2020–2034 (USD Million)
- 6. U.S. Sterilization Container Systems Market, by Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. U.S. Sterilization Container Systems Market, by Type, 2020-2034 (USD Million)
- 6.3. Perforated
- 6.3.1. U.S. Sterilization Container Systems Market, by Perforated, 2020–2034 (USD Million)
- 6.4. Non-Perforated
- 6.4.1. U.S. Sterilization Container Systems Market, by Non-Perforated, 2020–2034 (USD Million)
- 7. U.S. Sterilization Container Systems Market, by Technology
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. U.S. Sterilization Container Systems Market, by Filter, 2020-2034 (USD Million)
- 7.3. Filter
- 7.3.1. U.S. Sterilization Container Systems Market, by Aluminum, 2020–2034 (USD Million)
- 7.4. Valves
- 7.4.1. U.S. Sterilization Container Systems Market, by Valves, 2020–2034 (USD Million)
- 8. U.S. Sterilization Container Systems Market, by Material
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. U.S. Sterilization Container Systems Market, by Material, 2020-2034 (USD Million)
- 8.3. Aluminum
- 8.3.1. U.S. Sterilization Container Systems Market, by Aluminum, 2020–2034 (USD Million)
- 8.4. Stainless Steel
- 8.4.1. U.S. Sterilization Container Systems Market, by Stainless Steel, 2020–2034 (USD Million)
- 8.5. Other Material
- 8.5.1. U.S. Sterilization Container Systems Market, by Other Material, 2020–2034 (USD Million)
- 9. U.S. Sterilization Container Systems Market, by End User
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. U.S. Sterilization Container Systems Market, by End User, 2020-2034 (USD Million)
- 9.3. Hospitals
- 9.3.1. U.S. Sterilization Container Systems Market, by Hospitals, 2020-2034 (USD Million)
- 9.4. Ambulatory Surgical Centers
- 9.4.1. U.S. Sterilization Container Systems Market, by Ambulatory Surgical Centers, 2020-2034 (USD Million)
- 9.5. Others
- 9.5.1. U.S. Sterilization Container Systems Market, by Others, 2020-2034 (USD Million)
- 10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
- 11. Company Profiles
- 11.1. Aesculap, Inc. (B. Braun)
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. ASP
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Aspen Surgical Products, Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. CareFusion (BD)
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Case Medical
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Censis Technologies
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Integra LifeSciences
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Medline Industries, Inc.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Ritter Dental USA
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. STERIS
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Stryker
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


